Back to Search Start Over

Lifestyle improvement reduces the consumption of ultra-processed foods in adults with metabolic syndrome.

Authors :
Walker MS
Tarasiuk FS
Gustavo AS
Oliveira MS
Donadio MVF
Feoli AMP
Source :
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2022 Aug; Vol. 32 (8), pp. 1990-1997. Date of Electronic Publication: 2022 Apr 29.
Publication Year :
2022

Abstract

Background and Aims: The high consumption of ultra-processed products is a concern because it is positively associated with the incidence of chronic non-communicable diseases, as metabolic syndrome (MetS). The aim is to evaluate the effects of three different interventions to modify lifestyle on the consumption of ultra-processed foods in adults with MetS.<br />Methods and Results: This was a randomized clinical trial, in which the participants were divided into three groups: Standard Intervention (SI), Group Intervention (GI) and Individual Intervention (II). The interventions were carried out over a three-month period and the data was collected in a 24-h food record, taken at the beginning and end of the intervention. The food they ate was classified into four groups according to the degree of processing (unprocessed or minimally processed foods, processed culinary ingredients, processed foods, and ultra-processed foods) in accordance with the NOVA food classification. Seventy adults took part in the study with a mean age of 51.2 ± 6.6 years old; most of whom were female (55.7%). The amount of ultra-processed food consumed by the three groups (SI, GI and II) was significantly reduced (46%, 34%, and 33%, respectively). The amount of processed food consumed only reduced in the II group. The Total Energy Value (TEV) consumed by the SI and II groups decreased.<br />Conclusions: The interventions that were intended to alter lifestyles were able to reduce the amount of ultra-processed food consumed, which can have an impact on the prevention and treatment of MetS.<br />Registration: registered in the Brazilian Registry of Clinical Trials, ReBEC, under number: RBR-9wz5fc.<br />Competing Interests: Declaration of competing interest The authors state that there are no conflicts of interest in this work.<br /> (Copyright © 2022 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1590-3729
Volume :
32
Issue :
8
Database :
MEDLINE
Journal :
Nutrition, metabolism, and cardiovascular diseases : NMCD
Publication Type :
Academic Journal
Accession number :
35606223
Full Text :
https://doi.org/10.1016/j.numecd.2022.04.016